Aligos Therapeutics reported total assets of $0.05B and total liabilities of $0.04B for the quarter ended Sep 2026, down 57.0% year over year. This balance sheet covers 29 quarters of results from Sep 2019 through Sep 2026, standardized by Business Quant from the company’s SEC filings.
| Balance SheetBalance Sheet | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 | Sep2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||||||||||||
| Current Assets | |||||||||||||||||||||||||||||
| Cash & EquivalentsCash & Equiv. | 186.82M | 104.56M | 71.17M | 86.44M | 81.35M | 78.67M | 90.83M | 70.43M | 135.70M | 24.15M | 45.08M | 35.33M | 37.00M | 73.76M | 18.66M | 41.95M | 18.30M | 29.98M | 30.40M | 31.10M | |||||||||
| Short-term InvestmentsInvestments (Current) | 3.92M | 78.66M | 88.17M | 55.86M | 44.48M | 24.85M | 0.01M | -0.03M | 0.00M | 88.59M | 49.46M | 39.59M | 19.94M | 64.10M | 104.28M | 57.15M | 59.54M | 24.93M | |||||||||||
| Cash & Current Investments | 205.80M | 183.20M | 159.30M | 142.30M | 125.80M | 103.50M | 90.80M | 70.40M | 135.70M | 112.70M | 94.50M | 74.90M | 56.90M | 137.90M | 122.90M | 99.10M | 77.80M | 54.90M | 30.40M | 31.10M | |||||||||
| Receivables - NetNet Receivables | 27.78M | ||||||||||||||||||||||||||||
| Receivables | 27.78M | ||||||||||||||||||||||||||||
| Work In Process | 0.02M | 0.02M | 0.02M | 0.02M | 0.02M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | ||||||||||||||||
| Current Deferred Tax AssetsCurrent Deferred Tax | -109,560.00M | -34,235.00M | -56.52M | ||||||||||||||||||||||||||
| Prepaid Assets | 13.53M | 10.30M | 8.32M | 7.71M | 7.60M | 5.52M | 3.36M | 4.14M | 5.31M | 5.11M | 4.96M | 4.79M | 5.09M | 5.23M | 4.89M | 4.23M | 4.91M | 4.55M | 3.93M | 2.94M | |||||||||
| Current Assets | 204.42M | 195.08M | 167.69M | 150.09M | 133.55M | 109.43M | 94.24M | 74.64M | 141.08M | 118.06M | 99.57M | 79.82M | 62.14M | 143.21M | 127.94M | 103.44M | 82.86M | 59.63M | 62.13M | 34.68M | |||||||||
| Non-Current Assets | |||||||||||||||||||||||||||||
| Property, Plant & Equipment (Net)PP&E (Net) | 6.18M | 6.02M | 5.78M | 5.25M | 4.82M | 4.37M | 3.95M | 3.65M | 3.26M | 3.05M | 2.80M | 2.58M | 2.36M | 2.21M | 2.06M | 2.04M | 1.87M | 1.59M | 1.33M | 1.21M | |||||||||
| Long-Term Investments | 15.11M | ||||||||||||||||||||||||||||
| Long-Term Deferred Tax | 3,168.00M | 2,376.00M | 1.76M | ||||||||||||||||||||||||||
| Other Non-Current Assets | 1.03M | 1.56M | 0.02M | 0.08M | 0.75M | 0.40M | 0.04M | 0.70M | 0.70M | 0.84M | 0.70M | 0.64M | 0.63M | 0.63M | 0.64M | 0.71M | 0.72M | 0.76M | 0.76M | 0.27M | |||||||||
| Non-Current Assets | 30.95M | 15.39M | 14.84M | 13.98M | 13.15M | 12.31M | 11.89M | 11.21M | 10.44M | 9.84M | 9.24M | 8.60M | 7.95M | 7.49M | 6.76M | 6.33M | 5.67M | 4.93M | 4.20M | 12.51M | |||||||||
| Assets | 235.37M | 210.47M | 182.52M | 164.07M | 146.69M | 121.74M | 106.13M | 85.85M | 151.53M | 127.90M | 108.81M | 88.43M | 70.09M | 150.70M | 134.71M | 109.76M | 88.53M | 64.56M | 66.33M | 47.19M | |||||||||
| Liabilities | |||||||||||||||||||||||||||||
| Current Liabilities | |||||||||||||||||||||||||||||
| Accounts Payables | 3.02M | 3.76M | 2.76M | 2.93M | 4.74M | 2.82M | 3.24M | 2.94M | 2.52M | 2.84M | 6.82M | 2.74M | 2.57M | 4.46M | 3.94M | 4.65M | 3.98M | 7.64M | 6.43M | 3.21M | |||||||||
| Payables | 3.02M | 3.76M | 2.76M | 2.93M | 4.74M | 2.82M | 3.24M | 2.94M | 2.52M | 2.84M | 6.82M | 2.74M | 2.57M | 4.46M | 3.94M | 4.65M | 3.98M | 7.64M | 6.43M | 3.21M | |||||||||
| Accumulated Expenses | 25.39M | 19.24M | 12.82M | 13.68M | 16.04M | 15.08M | 13.80M | 12.32M | 16.84M | 12.04M | 12.06M | 14.16M | 15.56M | 11.00M | 12.21M | 13.61M | 13.53M | 11.99M | 18.70M | 15.15M | |||||||||
| Other Accumulated Expenses | 1.24M | 1.14M | 0.86M | 0.91M | 1.47M | 2.27M | 1.44M | 1.26M | 6.63M | 2.84M | 2.71M | 2.75M | 5.38M | 3.85M | 3.82M | 4.83M | 3.25M | 4.26M | 7.03M | 4.13M | |||||||||
| Current Leases | 0.14M | 0.14M | 0.14M | 0.14M | 0.11M | 0.11M | 0.06M | 0.06M | 0.01M | 0.01M | 0.00M | 0.01M | 0.04M | 0.04M | 0.04M | 0.02M | 0.15M | 0.08M | 0.06M | 0.06M | |||||||||
| Current Taxes | 106.00M | 795.00M | 331.00M | ||||||||||||||||||||||||||
| Current Deferred Revenue | 7.64M | 15.07M | 13.13M | 10.73M | 8.74M | 6.56M | 4.10M | 2.09M | 1.31M | 0.72M | 1.33M | 0.66M | 0.15M | 0.58M | 0.17M | ||||||||||||||
| Total Current Liabilities | 38.96M | 41.36M | 31.65M | 30.54M | 33.13M | 28.08M | 27.23M | 22.47M | 23.91M | 18.88M | 23.56M | 20.96M | 21.74M | 18.95M | 20.27M | 21.99M | 21.23M | 23.32M | 28.34M | 19.60M | |||||||||
| Non-Current Liabilities | |||||||||||||||||||||||||||||
| Capital Leases | 0.26M | 0.23M | 0.20M | 0.17M | 0.23M | 0.21M | 0.20M | 0.19M | 0.23M | 0.22M | 0.20M | 0.19M | 0.12M | 0.12M | 0.12M | 0.12M | |||||||||||||
| Non-Current Deferred Revenue | 5.01M | 3.25M | 1.56M | ||||||||||||||||||||||||||
| Preferred Stock Liabilities | |||||||||||||||||||||||||||||
| Non-Current Deferred Tax LiabilityNon-Current Deferred Tax | -3,168.00M | -2,376.00M | -1.76M | ||||||||||||||||||||||||||
| Operating Leases | 11.29M | 10.85M | 10.30M | 9.65M | 9.20M | 8.61M | 8.97M | 8.33M | 7.67M | 6.99M | 6.28M | 5.55M | 4.80M | 4.27M | 3.22M | 2.38M | 1.53M | 0.66M | 0.29M | 10.66M | |||||||||
| Other Non-Current Liabilities | 0.13M | 0.13M | 0.13M | 0.13M | 2,055.00M | 27.60M | 41.97M | 11.49M | 11.60M | 72.37M | |||||||||||||||||||
| Total Non-Current Liabilities | 0.13M | 57.45M | 45.41M | 41.92M | -2,012.21M | 0.05M | 0.05M | 0.05M | 0.05M | 0.05M | 0.05M | 0.05M | 0.05M | 0.05M | 0.05M | ||||||||||||||
| Total Liabilities | 50.64M | 57.58M | 45.54M | 42.06M | 42.79M | 36.99M | 36.50M | 31.03M | 59.45M | 68.11M | 41.58M | 38.33M | 99.07M | 34.25M | 32.84M | 37.93M | 34.99M | 32.77M | 34.44M | 35.88M | |||||||||
| Shareholder's Equity | |||||||||||||||||||||||||||||
| Common Equity | 184.73M | 152.89M | 136.98M | 122.01M | 103.90M | 84.75M | 69.64M | 54.82M | 92.08M | 59.80M | 67.23M | 50.10M | -28.97M | 116.45M | 101.87M | 71.83M | 53.55M | 31.79M | 31.88M | 11.31M | |||||||||
| Liabilities and Shareholders Equity | 235.37M | 210.47M | 182.52M | 164.07M | 146.69M | 121.74M | 106.13M | 85.85M | 151.53M | 127.90M | 108.81M | 88.43M | 70.09M | 150.70M | 134.71M | 109.76M | 88.53M | 64.56M | 66.33M | 47.19M | |||||||||
| Retained Earnings | -303.10M | -338.70M | -358.61M | -377.23M | -399.12M | -422.10M | -440.90M | -458.91M | -486.80M | -521.70M | -516.60M | -535.90M | -618.01M | -574.92M | -590.80M | -622.32M | -642.20M | -665.24M | -666.75M | -688.61M | |||||||||
| Preferred Shares |
Pull Aligos Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/statements?ticker=ALGS&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/statements"
params = {"ticker": "ALGS", "statement": "BS", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/statements?ticker=ALGS&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();